<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02889614</url>
  </required_header>
  <id_info>
    <org_study_id>RC15_0345</org_study_id>
    <nct_id>NCT02889614</nct_id>
  </id_info>
  <brief_title>Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia</brief_title>
  <acronym>HYPOPSY</acronym>
  <official_title>Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Familial hypobetalipoproteinemia (FHBL, OMIM # 1707730) is a genetic disorder heterozygotic
      of LDL-C metabolism. Clinical manifestation range from asymptomatic patients to metabolic
      (fatty liver, diabetes) or psychiatric disorders still unrecognized. HYPOPSY research, aims
      to evaluate prevalence of hypobetalipoproteinemia, and to characterize specific related
      psychiatric disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Familial hypobetalipoproteinemia (FHBL, OMIM # 1707730) is a genetic disorder heterozygotic
      of LDL-C metabolism (Low Density Lipoprotein - Cholesterol) whose incidence is measured from
      1: 500 to 1: 1000. These heterozygous individuals may be asymptomatic or present some
      clinical (fatty liver, diabetes) or psychiatric manifestations still unrecognized. Moreover,
      these individuals have mostly a longevity syndrome and cardiovascular protection. The FHBL is
      often due to mutations of the APOB (APOlipoprotein B), major component of LDL, VLDL (Very Low
      Density Lipoprotein) and chylomicrons, and in some cases, loss-of-function mutations of the
      serine protease PCSK9, endogenous inhibitor of the LDL receptor.

      HYPOPSY research, aims to evaluate, in a population with psychiatric disorders, the
      prevalence of hypobetalipoproteinemia, and to characterize specific related psychiatric
      disorders.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">July 31, 2015</completion_date>
  <primary_completion_date type="Actual">July 31, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of hypobetalipoproteinemia (LDL-C ≤ 50 mg/dL without hypolipidemic treatment) among psychiatric patients managed in Nantes University Hospital</measure>
    <time_frame>Inclusion.</time_frame>
    <description>Dosage of LDL-C</description>
  </primary_outcome>
  <enrollment type="Actual">3000</enrollment>
  <condition>Hypobetalipoproteinemia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypobetalipoproteinemia diagnosis (LDL-C ≤ 50 mg/dL without hypolipidemic treatment)</intervention_name>
    <description>LDL-C dosage.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted in mental Disorders Unit in Nantes University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted in mental Disorders Unit in Nantes University Hospital

        Exclusion Criteria:

          -  Minor patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>July 11, 2017</last_update_submitted>
  <last_update_submitted_qc>July 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Hypobetalipoproteinemias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

